We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
+16.69%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.1M
AUM Growth
-$60.7M
Cap. Flow
-$85.3M
Cap. Flow %
-112.09%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TYRA icon
Tyra Biosciences
TYRA
+$85M
2
RLYB icon
Rallybio
RLYB
+$309K
3
BLNK icon
Blink Charging
BLNK
+$579

Sector Composition

Rank Sector Weight
1 Technology 62.23%
2 Healthcare 37.76%
3 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEVA
1
Aeva Technologies
AEVA
$1.02B
$47.3M 62.23%
3,597,039
– –
TYRA icon
2
Tyra Biosciences
TYRA
$1.82B
$28.7M 37.76%
750,000
-2,624,329
-78% -$85M
BLNK icon
3
Blink Charging
BLNK
$75.2M
$5.35K 0.01%
9,439
-821
-8% -$579
RLYB icon
4
Rallybio
RLYB
$86.6M
– –
-56,250
Closed -$309K

Similar funds

ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
MF
Midwestern Financial Iowa City, Iowa $127M AUM 13.96% 1-Year Est. Return
SAP
Strategic Advisory Partners Greensboro, North Carolina $127M AUM
S
Storgate Dallas, Texas $127M AUM
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
VDC
Van Diest Capital Poly City, Iowa $127M AUM
PA
Persium Advisors Atlanta, Georgia $127M AUM 18.78% 1-Year Est. Return

Canaan Partners XI's Q1 2026 Portfolio in Review

As of Q1 2026, Canaan Partners XI held 4 positions worth $76.1M, down 44% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners XI withdrew a net $85.3M in Q1 2026, closing 1 position and reducing 2 holdings. Its most notable exit was Rallybio, an estimated $309K position sold in full.

By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Canaan Partners XI's biggest Q1 2026 reduction was Tyra Biosciences, cutting an estimated $85M.
  • Canaan Partners XI fully exited Rallybio in Q1 2026, selling an estimated $309K.
  • Canaan Partners XI's ten largest holdings make up 100% of its $76.1M portfolio in Q1 2026.
  • Canaan Partners XI opened 0 new positions and closed 1 in Q1 2026.
  • Canaan Partners XI's portfolio value fell 44% quarter-over-quarter to $76.1M.

Based on Canaan Partners XI's 13F filing for Q1 2026, filed 24 Apr 2026.